34 related articles for article (PubMed ID: 23181521)
21. How close are we to having structure-modifying drugs available?
Hunter DJ; Hellio Le Graverand-Gastineau MP
Rheum Dis Clin North Am; 2008 Aug; 34(3):789-802. PubMed ID: 18687283
[TBL] [Abstract][Full Text] [Related]
22. The use of advanced biological and tissue-engineered wound products.
Collier M
Nurs Stand; 2006 Oct 25-31; 21(7):68, 70, 72 passim. PubMed ID: 17087417
[TBL] [Abstract][Full Text] [Related]
23. [Available evidence about efficacy of different restoring agents of glycosaminoglycans for intravesical use in interstitial cystitis].
Arance I; Ramón de Fata F; Angulo JC; González-Enguita C; Errando C; Cozar JM; Esteban M
Actas Urol Esp; 2013 Feb; 37(2):92-9. PubMed ID: 23260184
[TBL] [Abstract][Full Text] [Related]
24. Knee osteoarthritis management therapies.
Leslie M
Pain Manag Nurs; 2000 Jun; 1(2):51-7. PubMed ID: 11706459
[TBL] [Abstract][Full Text] [Related]
25. Restoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations.
Cicione A; Cantiello F; Ucciero G; Salonia A; Madeo I; Bava I; Aliberti A; Damiano R
Int J Urol; 2014 Aug; 21(8):763-8. PubMed ID: 24640993
[TBL] [Abstract][Full Text] [Related]
26. Prevention of recurrent urinary tract infections in women.
Drug Ther Bull; 2013 Jun; 51(6):69-72. PubMed ID: 23766394
[TBL] [Abstract][Full Text] [Related]
27. [Urinary tract infections and their prevention].
González-Chamorro F; Palacios R; Alcover J; Campos J; Borrego F; Dámaso D
Actas Urol Esp; 2012 Jan; 36(1):48-53. PubMed ID: 21757260
[TBL] [Abstract][Full Text] [Related]
28. New preclinical data - the case for Ialuril®.
Salonia A
Urologia; 2016 Jun; 83 Suppl 1():15-9. PubMed ID: 27405345
[TBL] [Abstract][Full Text] [Related]
29. Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections.
Ha US; Cho YH
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S63-7. PubMed ID: 17913471
[TBL] [Abstract][Full Text] [Related]
30. Editorial comment to intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
Damiano R; Cicione A
Int J Urol; 2012 Dec; 19(12):1112-3. PubMed ID: 23181521
[No Abstract] [Full Text] [Related]
31. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis.
Goddard JC; Janssen DAW
Int Urogynecol J; 2018 Jul; 29(7):933-942. PubMed ID: 29181550
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis?
Iavazzo C; Athanasiou S; Pitsouni E; Falagas ME
Eur Urol; 2007 Jun; 51(6):1534-40; discussion 1540-1. PubMed ID: 17383810
[TBL] [Abstract][Full Text] [Related]
33. [Arthroses: futility or challenge--a survey of the actual situation].
Pfister JA
Rev Med Suisse Romande; 2001 Nov; 121(11):851-7. PubMed ID: 11765572
[No Abstract] [Full Text] [Related]
34. Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and
Crocetto F; Balsamo R; Amicuzi U; De Luca L; Falcone A; Mirto BF; Giampaglia G; Ferretti G; Capone F; Machiella F; Varriale D; Sicignano E; Pagano G; Lombardi A; Lucarelli G; Lasorsa F; Busetto GM; Del Giudice F; Ferro M; Imbimbo C; Barone B
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630763
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
